Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Diabetes Care|May 1, 1995
Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart StudyE T Lee, B V Howard, P J Savage, et al.
The American Journal of Cardiology|May 30, 2001
Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study)J N Bella, R B Devereux, M J Roman, et al.
American Journal of Hypertension|October 6, 2001
Hypertension treatment patterns in American Indians: the strong heart studyJ A Hayslett, J E Eichner, J L Yeh, et al.
American Heart Journal|May 29, 2001
Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart StudyA Ilercil, R B Devereux, M J Roman, et al.
Circulation|May 16, 2000
Impact of diabetes on cardiac structure and function: the strong heart studyR B Devereux, M J Roman, M Paranicas, et al.
The American Journal of Cardiology|December 15, 1996
Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study)A J Oopik, M Dorogy, R B Devereux, et al.
American Journal of Epidemiology|August 1, 1995
Cardiovascular disease risk factors among American Indians. The Strong Heart StudyT K Welty, E T Lee, J Yeh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1996
Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart StudyS Kataoka, D C Robbins, L D Cowan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart StudyR S Gray, D C Robbins, W Wang, et al.
Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.
Pageof 20